SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-19-000954
Filing Date
2019-03-06
Accepted
2019-03-06 17:27:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a2237867zs-3.htm S-3 414334
2 EX-1.2 a2237867zex-1_2.htm EX-1.2 262204
3 EX-4.7 a2237867zex-4_7.htm EX-4.7 421551
4 EX-4.8 a2237867zex-4_8.htm EX-4.8 435906
5 EX-5.1 a2237867zex-5_1.htm EX-5.1 45588
6 EX-23.1 a2237867zex-23_1.htm EX-23.1 3076
7 G55912KYI001.GIF g55912kyi001.gif GRAPHIC 2327
  Complete submission text file 0001047469-19-000954.txt   1587096
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-230108 | Film No.: 19663527
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences